Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
about
Pyruvate Kinase M2: A Potential Target for Regulating InflammationThe sweet trap in tumors: aerobic glycolysis and potential targets for therapyIs cancer a metabolic disease?Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory DiseasesEnhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.Tumor bioenergetics: an emerging avenue for cancer metabolism targeted therapyMultifunctional gold nanorods for siRNA gene silencing and photothermal therapy.Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesisDiversity in TAF proteomics: consequences for cellular differentiation and migration.PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathwaysRole of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2.Epidermal growth-factor-induced transcript isoform variation drives mammary cell migration.Protein-tyrosine phosphatase 1B substrates and metabolic regulationOrgan-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms.PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinomaActivators of PKM2 in cancer metabolism.Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.Targeting glucose metabolism for cancer therapy.Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian CancerBiological Relevance and Therapeutic Potential of the Hypusine Modification System.Overexpression of pyruvate kinase M2 associates with aggressive clinicopathological features and unfavorable prognosis in oral squamous cell carcinoma.Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer TherapyEmerging roles of PKM2 in cell metabolism and cancer progressionTargeting cancer metabolism.Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotidesLong Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activationMYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.PKM2 and cancer: The function of PKM2 beyond glycolysis.Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma.EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape.Protein tyrosine phosphatase 1B regulates pyruvate kinase M2 tyrosine phosphorylationIn Vivo GFP Knockdown by Cationic Nanogel-siRNA PolyplexesUp-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer.Knockdown of copper chaperone antioxidant-1 by RNA interference inhibits copper-stimulated proliferation of non-small cell lung carcinoma cells.
P2860
Q26752535-D500CAD3-16F8-4589-B1CC-008D58D03E94Q26766079-D7C19297-315C-4743-BBF4-72BFD504DB9FQ26852241-B7E535A9-E32A-4549-BC7D-0F38F5541823Q28548580-C7829DAC-FCAC-4E34-8ED6-E978D1F24DCCQ33739006-3386A490-57CE-4AAD-B799-5F82EA4C4F9AQ34179999-2FA6B5FE-0A8F-4DA8-A4D8-F18AC4ABBBA6Q34276290-79FCC6B4-66BB-4B9F-8E83-BEABCE2362B2Q34338923-B5A0E9FF-F332-464C-83CD-AA6AE95471A9Q34358974-4BCE96B6-FB7E-4880-9AA9-F0D90F532163Q34377342-E31A69F6-E416-487A-8D12-50BEBC687580Q34390494-FD6020D0-2D03-4173-BA93-023A770D9F4BQ34442342-E0C843C0-C146-41F3-AACD-E7C207D699FFQ34498995-844F7E45-40A6-4EC5-A8CB-86785BD1DDADQ35063756-0D3AD515-9848-4102-AD09-FE3DC22D007EQ35118726-CBE67849-489F-46D5-87A9-90FEBB6F92FAQ35126891-046AB53C-1516-4FE1-BB26-8B4567F576F2Q35176162-42DCA7BA-D1AF-46FA-B11E-1208C49EC8C5Q35215989-453B5ABA-5BB7-4C00-B776-9EBDF7859E74Q35740029-5033D75A-946F-4BB4-9BC5-946E31FE992FQ35751116-CEC9964F-9735-44F4-9102-B8253CE3B474Q35760864-2E9BF232-B34C-4358-B838-DE6F67C1D18DQ35836455-139E67E6-23F0-4D61-9010-C3D07EE7FBA4Q35883784-5D8B7B1E-8248-418F-88EB-0F3FCAB8A387Q36213166-65A8532A-7BCA-442C-ACC6-5EE31C01E6E8Q36284940-9B45121C-EE27-417E-9384-EC499DBF0D31Q36303571-6712A2C3-EBD5-43D8-9703-038CE9804730Q36330869-90E89670-534C-4303-9B72-742C3F11A11BQ36401195-EAA7CEF7-D2DD-4719-AFE7-FD207A84EECDQ36405508-776B20A0-A88F-4498-989F-97B18FAC6B72Q36414207-3E9717A9-012F-4F33-B5E4-175C14AA569CQ36439595-1AB91DC6-C162-41D1-9A1A-6C769CC0935CQ36535291-488FA827-F04D-4ECC-A6B6-86B2C6560BB1Q36608747-DD91995C-53B8-4EAE-99A2-2C9B1876EEA9Q36640175-58EEB41F-4521-4F15-AC70-362933208EC7Q36641553-4F75FD73-125B-4606-A9C3-42F79CF122B5Q36642685-65595FCF-3874-468C-84CF-9C205000FE8BQ36928998-8A0B7777-B103-4DD1-BC2D-B5BD778057AAQ36973296-2EB31479-D30A-4281-97DD-64D3A37E08C3Q36990673-0A17B3B3-B5E1-427F-953A-F5CCC03276A3Q37059403-96202142-AFC1-4086-9967-0C71A9E96837
P2860
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
@ast
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
@en
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
@nl
type
label
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
@ast
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
@en
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
@nl
prefLabel
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
@ast
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
@en
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
@nl
P2860
P356
P1476
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
@en
P2093
Michael S Goldberg
Phillip A Sharp
P2860
P304
P356
10.1084/JEM.20111487
P407
P577
2012-01-23T00:00:00Z